Evaluating the affect of Rapamycin in Alzheimer's disease (ERAP phase IIa clinical study protocol)

Reading this protocol is a nice summary of evidence to date for the use of Rapamycin to treat/prevent Alzheimer’s. I couldn’t find that someone else had posted this study protocol that came out in April 2024.


Very interesting, thanks for posting. As an ApoE4 homozygote I’m keeping my fingers crossed that rapamycin has a positive effect


This study will provide us longevity types a fair bit of information when it’s completed.

It’s design is very close to what many use as a longevity intervention and it has a lot of good references for those who are new to Rapa.

1 Like